BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $704,909 | +21.7% | 114,063 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $579,440 | -49.2% | 114,063 | -40.1% | 0.00% | -57.1% |
| Q4 2023 | $1,141,341 | +84506.4% | 190,541 | 0.0% | 0.01% | -22.2% |
| Q3 2023 | $1,349 | +0.6% | 190,541 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $1,341 | +70.2% | 190,541 | +101.8% | 0.01% | +50.0% |
| Q1 2023 | $788 | -30.8% | 94,440 | -4.7% | 0.01% | -33.3% |
| Q4 2022 | $1,138 | -99.9% | 99,086 | -5.5% | 0.01% | -10.0% |
| Q3 2022 | $1,321,000 | +19.1% | 104,829 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $1,109,000 | -35.0% | 104,829 | 0.0% | 0.01% | -20.0% |
| Q1 2022 | $1,705,000 | +17.9% | 104,829 | 0.0% | 0.01% | +42.9% |
| Q4 2021 | $1,446,000 | -4.0% | 104,829 | 0.0% | 0.01% | -12.5% |
| Q3 2021 | $1,506,000 | – | 104,829 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |